Dr. Kasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2650 Shawnee Mission Pkwy
Fairway, KS 66205Phone+1 913-588-4085Fax+1 913-588-9822- Is this information wrong?
Education & Training
University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 2012 - 2015- University of Kansas School of MedicineFellowship, Gastro Intestinal Medical Oncology, 2014 - 2014
- University of Kansas School of MedicineResidency, Internal Medicine, 2009 - 2012
University of TexasPublic Health, 2008 - 2009
Bangalore Medical CollegeClass of 2008
Certifications & Licensure
MO State Medical License 2021 - 2025
KS State Medical License 2015 - 2024
Awards, Honors, & Recognition
- Junior Faculty Travel Award for poster presentation KU Cancer Center, 2016
- Fellow Grant to attend Coagulation Disorder Workshop Hemostasis and Thrombosis Research Society, 2013
- Second prize in oral presentation at ACP plenary session American College of Physicians, 2010
- Join now to see all
Clinical Trials
- Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial Start of enrollment: 2019 Jan 22
- Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer Start of enrollment: 2019 May 10
- Trial to Evaluate Safety and Tolerability of GP-2250 in Combination With Gemcitabine Start of enrollment: 2019 Jan 14
Roles: Study Chair, Contact
- Join now to see all
Publications & Presentations
PubMed
- Comparative molecular profiling of pancreatic ductal adenocarcinoma of the head versus body and tail.Abdullah Esmail, Joanne Xiu, Yasmine Baca, Maen Abdelrahim, Anup Kasi, Nestor F Esnaola, Benjamin A Weinberg> ;NPJ Precision Oncology. 2024 Apr 6
- Metastatic Adenocarcinoma of Intestinal Origin in Reconstructed Ureters.Priyanka Venkatesh, Weijing Sun, Louis Wetzel, Anup Kasi> ;Cureus. 2024 Mar 1
- Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA ...Anwaar Saeed, Robin Park, Harsh Pathak, Ayah Nedal Al-Bzour, Junqiang Dai, Milind Phadnis, Raed Al-Rajabi, Anup Kasi, Joaquina Baranda, Weijing Sun, Stephen Williamson...> ;Nature Communications. 2024 Feb 20
- Join now to see all
Press Mentions
Targovax Announces Dosing of First Subject with TG01 for Pancreatic CancerMarch 15th, 2023- Center Creating Rapid Next-Gen Medical Tests Wins $6.6M NIH FundingMay 12th, 2022
- Panavance Announces Abstract and Poster at ASCO Gastrointestinal Cancers Symposium, Providing an Update on the Status of GP-2250 Clinical Trial in Pancreatic Cancer PatientsJanuary 19th, 2022
- Join now to see all
Hospital Affiliations
The University of Kansas HospitalKansas City, Kansas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
